Key Benefits
Eptifab 20mg Injection 10ml contains Eptifibatide, which belongs to the monoclonal anti-glycoprotein IIb/IIIa receptor antibodies class. It works by blocking the glycoprotein IIb/IIIa receptor’s activity, thereby preventing platelet aggregation. This causes inhibition of fibrinogen binding, reducing the chance of blood clot formation. Eptifab 20mg Injection 10ml results in reducing the risk of cardiovascular events like myocardial infarction (heart attack) and other cardiac events.
Directions for Use
Side Effects
- Bleeding
- Nausea
- Headache
- Abdominal pain
- Hypotension
- Vomiting
- Dizziness
- Low platelet count
- Pain at the site of injection